Details for 2017776200
Up to date per 03.04.2026
Actions
Details for 2017776200
Granted/Registered
European Patent
06.02.2019 A
04.05.2022 B1
01.04.2016
US
201662316663 P
B01D 33/50 20060101AFI20191106BHEP
Owner
Mallinckrodt Pharmaceuticals Ireland LimitedCollege Business & Technology Park Cruiserath, Blanchardstown Dublin 15IE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
BIBA, Scott, I.512 Dorn Drive Waunakee WI 53597US
FALLIGANT, John335 Craig Road Edgerton WI 53534US
Information about Fees